Prof. Lambe’s research interest lies in the development of efficacious vaccines, principally toward influenza and outbreak pathogens, with a particular focus on CCHFV, Nipah virus, and filoviruses. Prof. Lambe has extensive knowledge in the assessment of naturally acquired and post-vaccination immune responses. Her previous works, delineating the establishment and maintenance of adaptive immune memory, have been rationally applied to augment and improve vaccine development. Her research team is currently focused on developing vaccines against viral haemorrhagic fevers and Nipah virus. Prof. Lambe also actively contributes to and collaborates with other Jenner Institute investigators on programs for Lassa fever virus and Middle East Respiratory Syndrome (MERS).